» Articles » PMID: 38400059

Beyond Impairment of Virion Infectivity: New Activities of the Anti-HIV Host Cell Factor SERINC5

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2024 Feb 24
PMID 38400059
Authors
Affiliations
Soon will be listed here.
Abstract

Members of the serine incorporator (SERINC) protein family exert broad antiviral activity, and many viruses encode SERINC antagonists to circumvent these restrictions. Significant new insight was recently gained into the mechanisms that mediate restriction and antagonism. In this review, we summarize our current understanding of the mode of action and relevance of SERINC proteins in HIV-1 infection. Particular focus will be placed on recent findings that provided important new mechanistic insights into the restriction of HIV-1 virion infectivity, including the discovery of SERINC's lipid scramblase activity and its antagonism by the HIV-1 pathogenesis factor Nef. We also discuss the identification and implications of several additional antiviral activities by which SERINC proteins enhance pro-inflammatory signaling and reduce viral gene expression in myeloid cells. SERINC proteins emerge as versatile and multifunctional regulators of cell-intrinsic immunity against HIV-1 infection.

Citing Articles

The Effects of Viral Structural Proteins on Acidic Phospholipids in Host Membranes.

de Souza Cardoso R, Ono A Viruses. 2024; 16(11).

PMID: 39599829 PMC: 11599007. DOI: 10.3390/v16111714.


Interactions between HIV proteins and host restriction factors: implications for potential therapeutic intervention in HIV infection.

Rashid F, Zaongo S, Iqbal H, Harypursat V, Song F, Chen Y Front Immunol. 2024; 15:1390650.

PMID: 39221250 PMC: 11361988. DOI: 10.3389/fimmu.2024.1390650.


Disruption of Transmembrane Phosphatidylserine Asymmetry by HIV-1 Incorporated SERINC5 Is Not Responsible for Virus Restriction.

Raghunath G, Abbott E, Marin M, Wu H, Reyes Ballista J, Brindley M Biomolecules. 2024; 14(5).

PMID: 38785977 PMC: 11118262. DOI: 10.3390/biom14050570.

References
1.
Pereira E, daSilva L . HIV-1 Nef: Taking Control of Protein Trafficking. Traffic. 2016; 17(9):976-96. DOI: 10.1111/tra.12412. View

2.
Haider T, Snetkov X, Jolly C . HIV envelope tail truncation confers resistance to SERINC5 restriction. Proc Natl Acad Sci U S A. 2021; 118(21). PMC: 8166163. DOI: 10.1073/pnas.2101450118. View

3.
Li W, Zhang Z, Zhang L, Li H, Fan S, Zhu E . Antiviral Role of Serine Incorporator 5 (SERINC5) Proteins in Classical Swine Fever Virus Infection. Front Microbiol. 2020; 11:580233. PMC: 7498654. DOI: 10.3389/fmicb.2020.580233. View

4.
Kmiec D, Kirchhoff F . Antiviral factors and their counteraction by HIV-1: many uncovered and more to be discovered. J Mol Cell Biol. 2024; 16(2). PMC: 11334937. DOI: 10.1093/jmcb/mjae005. View

5.
Obermaier B, Ananth S, Tibroni N, Pierini V, Shytaj I, Diaz R . Patient-Derived HIV-1 Nef Alleles Reveal Uncoupling of CD4 Downregulation and SERINC5 Antagonism Functions of the Viral Pathogenesis Factor. J Acquir Immune Defic Syndr. 2020; 85(2):e23-e26. DOI: 10.1097/QAI.0000000000002418. View